HomeNDC LookupRxCUI directory › RxCUI 1665057

2 ML verapamil hydrochloride 2.5 MG/ML Injection — RxCUI 1665057

RxNorm drug concept · Semantic clinical drug
RxCUI 1665057 Semantic clinical drug · SCD ● Current RxNorm concept 43 FDA products 61 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665057
Official name2 ML verapamil hydrochloride 2.5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asverapamil HCl 5 MG per 2 ML Injection; verapamil HCl 5 MG in 2 ML Injection
FDA products mapped43
Package NDCs mapped61
Reported Medicaid activity (SDUD)1,928 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Verapamil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That depends on why your doctor prescribed it. Verapamil can treat three main problems: high blood pressure, angina (chest pain from the heart not getting enough blood), and certai...
  • What exactly is verapamil treating in my body?
  • Yes, and it depends on your specific formulation. If you have the extended-release tablets, take them in the morning with food. If you have the extended-release PM capsules, take t...
  • Does it matter when I take verapamil or whether I take it with food?
📖 Read our full Verapamil guide →

🕸️ Concept Web — How 2 ML verapamil hydrochloride 2.5 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML verapamil hydrochloride 2.5 MG/ML Injection RxCUI 1665057

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Verapamil 11170
    • Verapamil hydrochloride 203138
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Verapamil Injection 1665056
    • Verapamil hydrochloride Injection 2648422
    • Verapamil Injectable Product 1160510
    • Verapamil hydrochloride Injectable Product 2663341
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Verapamil hydrochloride 2.5 MG/ML 897705

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Verapamil hydrochloride 2.5 MG/ML SCDC · 897705
  • Verapamil Injection SCDF · 1665056
  • Verapamil hydrochloride Injection SCDFP · 2648422
  • Verapamil Injectable Product SCDG · 1160510
  • Verapamil hydrochloride Injectable Product SCDGP · 2663341

📦 FDA Products & Package NDCs

43 products · 61 package NDCs
61 package NDCs map to RxCUI 1665057 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70771-1602-05 5 VIAL in 1 CARTON (70771-1602-5) / 4 mL in 1 VIAL (70771-1... Verapamil Hydrochloride Zydus Lifesciences Limited 2020-10-22
71872-7048-01 1 VIAL in 1 BAG (71872-7048-1) / 2 mL in 1 VIAL Verapamil Hydrochloride Medical Purchasing Solutions, LLC 2018-02-28
71872-7183-01 1 VIAL in 1 BAG (71872-7183-1) / 2 mL in 1 VIAL Verapamil Hydrochloride Medical Purchasing Solutions, LLC 2019-11-18
71872-7203-01 1 VIAL in 1 BAG (71872-7203-1) / 2 mL in 1 VIAL Verapamil Hydrochloride Medical Purchasing Solutions, LLC 2020-02-12
71872-7210-01 1 VIAL in 1 BAG (71872-7210-1) / 2 mL in 1 VIAL Verapamil Hydrochloride Medical Purchasing Solutions, LLC 2020-03-30
71872-7243-01 1 VIAL in 1 BAG (71872-7243-1) / 2 mL in 1 VIAL Verapamil Hydrochloride Medical Purchasing Solutions, LLC 2021-03-12
71872-7291-01 1 VIAL in 1 BAG (71872-7291-1) / 2 mL in 1 VIAL Verapamil Hydrochloride Medical Purchasing Solutions, LLC 2022-06-03
71872-7356-01 1 VIAL in 1 BAG (71872-7356-1) / 2 mL in 1 VIAL verapamil hydrochloride Medical Purchasing Solutions, LLC. 2025-08-10
72485-0108-05 5 VIAL in 1 CARTON (72485-108-05) / 2 mL in 1 VIAL (72485-1... Verapamil Hydrochloride Armas Pharmaceuticals Inc. 2020-01-01
72485-0108-25 25 VIAL in 1 CARTON (72485-108-25) / 2 mL in 1 VIAL (72485-... Verapamil Hydrochloride Armas Pharmaceuticals Inc. 2020-01-01
84549-0605-25 2 mL in 1 VIAL (84549-605-25) verapamil hydrochloride ProPharma Distribution 2025-08-27
Observed labelers: Eugia US LLC (6) · HF Acquisition Co LLC, DBA HealthFirst (6) · Medical Purchasing Solutions, LLC (6) · Micro Labs Limited (5) · Somerset Therapeutics, LLC (5) · EXELA PHARMA SCIENCES, LLC (4) · +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.